Physician profile
Matthew E Spector
NPI 1487863684
$55,785.33
in general payments reported to CMS, 2019-2025
11 companies · $28K in 2025
The $28K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $359 · 2021: $90.00 · 2022: $149 · 2023: $18K · 2024: $9,210 · 2025: $28K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $29K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Travel and Lodging: $3,900 · Food and Beverage: $3,242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $28,626.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,420.00 |
| Travel and Lodging | $3,899.52 |
| Food and Beverage | $3,242.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $17,140.17 | 2024-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Hologic Sales and Service, LLC | $16,898.54 | 2022-2025 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $14,297.28 | 2024-2025 | Keytruda |
| Emd Serono, INC. | $4,725.00 | 2023 | |
| Kls-Martin L.P. | $1,693.87 | 2023-2024 | |
| Integra Lifesciences Corporation | $274.25 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Inspire Medical Systems, INC. | $261.95 | 2025 | Inspire |
| Stryker Corporation | $210.11 | 2019 | |
| Intersect Ent, INC. | $148.57 | 2019 | |
| Intuitive Surgical, INC. | $90.00 | 2021 | |
| Coherus Oncology, INC. | $45.59 | 2025 | Loqtorzi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Spector listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.